RiverVest Venture Fund III, L.P. 13D and 13G filings for Reneo Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-21 6:38 pm Sale |
2025-01-16 | 13D | Reneo Pharmaceuticals, Inc. RPHM |
RiverVest Venture Fund III, L.P. | 196,198 1.550% |
-57,224 (-22.58%) |
Filing |
| 2023-05-30 4:52 pm Purchase |
2023-05-08 | 13D | Reneo Pharmaceuticals, Inc. RPHM |
RiverVest Venture Fund III, L.P. | 253,422 7.530% |
12,500 (+5.19%) |
Filing |
| 2021-04-19 2:04 pm Purchase |
2021-04-08 | 13D | Reneo Pharmaceuticals, Inc. RPHM |
RiverVest Venture Fund III, L.P. | 240,922 10.000% |
240,922 (New Position) |
Filing |